A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Drug: Teclistamab
Sites in Rochester, Minneapolis +33 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07518186·Phase 3·Recruiting·Listed Apr 2026